313 related articles for article (PubMed ID: 26666459)
1. Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study.
Martin L; Harris MT; Brooks A; Main C; Mertz D
BMC Infect Dis; 2015 Dec; 15():568. PubMed ID: 26666459
[TBL] [Abstract][Full Text] [Related]
2. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
Eby JC; Richey MM; Platts-Mills JA; Mathers AJ; Novicoff WM; Cox HL
Clin Infect Dis; 2018 Jan; 66(1):64-71. PubMed ID: 29020181
[TBL] [Abstract][Full Text] [Related]
3. An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia.
Wenzler E; Wang F; Goff DA; Prier B; Mellett J; Mangino JE; Bauer KA
Clin Infect Dis; 2017 Jul; 65(2):194-200. PubMed ID: 28379326
[TBL] [Abstract][Full Text] [Related]
4. Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
Rosa R; Wawrzyniak A; Sfeir M; Smith L; Abbo LM
J Hosp Med; 2016 Jan; 11(1):27-32. PubMed ID: 26381394
[TBL] [Abstract][Full Text] [Related]
5. Reduction of 30-day death rates from Staphylococcus aureus bacteremia by mandatory infectious diseases consultation: Comparative study interventions with and without an infectious disease specialist.
Hadano Y; Kakuma T; Matsumoto T; Ishibashi K; Isoda M; Yasunaga H
Int J Infect Dis; 2021 Feb; 103():308-315. PubMed ID: 33278619
[TBL] [Abstract][Full Text] [Related]
6. Impact of a Best Practice Advisory for Pediatric Patients With Staphylococcus aureus Bacteremia.
Lloyd EC; Martin ET; Dillman N; Nagel J; Chang R; Gandhi TN; Tribble AC
J Pediatric Infect Dis Soc; 2021 Apr; 10(3):282-288. PubMed ID: 32531048
[TBL] [Abstract][Full Text] [Related]
7. Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
Smith JR; Frens JJ; Snider CB; Claeys KC
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):50-54. PubMed ID: 29153470
[TBL] [Abstract][Full Text] [Related]
8. Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review.
Buehrle K; Pisano J; Han Z; Pettit NN
Am J Infect Control; 2017 Jul; 45(7):713-716. PubMed ID: 28431847
[TBL] [Abstract][Full Text] [Related]
9. Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study.
Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
Clin Infect Dis; 2015 May; 60(10):1451-61. PubMed ID: 25701854
[TBL] [Abstract][Full Text] [Related]
10. Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.
Goto M; Schweizer ML; Vaughan-Sarrazin MS; Perencevich EN; Livorsi DJ; Diekema DJ; Richardson KK; Beck BF; Alexander B; Ohl ME
JAMA Intern Med; 2017 Oct; 177(10):1489-1497. PubMed ID: 28873140
[TBL] [Abstract][Full Text] [Related]
11. Association of Infectious Diseases Consultation With Long-term Postdischarge Outcomes Among Patients With Staphylococcus aureus Bacteremia.
Goto M; Jones MP; Schweizer ML; Livorsi DJ; Perencevich EN; Richardson K; Beck BF; Alexander B; Ohl ME
JAMA Netw Open; 2020 Feb; 3(2):e1921048. PubMed ID: 32049296
[TBL] [Abstract][Full Text] [Related]
12. Impact of infectious disease consultation on patients with Staphylococcus aureus bacteremia at a Japanese tertiary hospital: A retrospective observational study.
Suzuki J; Sasahara T; Minami K; Morisawa Y; Yamada T
J Infect Chemother; 2020 Aug; 26(8):780-784. PubMed ID: 32423701
[TBL] [Abstract][Full Text] [Related]
13. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
[TBL] [Abstract][Full Text] [Related]
14. Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System.
Turner RB; Valcarlos E; Won R; Chang E; Schwartz J
Antimicrob Agents Chemother; 2016 Oct; 60(10):5682-7. PubMed ID: 27401580
[TBL] [Abstract][Full Text] [Related]
15. Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study.
Forsblom E; Kakriainen A; Ruotsalainen E; Järvinen A
Infection; 2018 Dec; 46(6):837-845. PubMed ID: 30194636
[TBL] [Abstract][Full Text] [Related]
16. Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.
Rieg S; Küpper MF
Infection; 2016 Apr; 44(2):159-66. PubMed ID: 26908131
[TBL] [Abstract][Full Text] [Related]
17. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.
Nagao M; Yamamoto M; Matsumura Y; Yokota I; Takakura S; Teramukai S; Ichiyama S
Infection; 2017 Feb; 45(1):83-91. PubMed ID: 27709434
[TBL] [Abstract][Full Text] [Related]
18. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia.
López-Cortés LE; Del Toro MD; Gálvez-Acebal J; Bereciartua-Bastarrica E; Fariñas MC; Sanz-Franco M; Natera C; Corzo JE; Lomas JM; Pasquau J; Del Arco A; Martínez MP; Romero A; Muniain MA; de Cueto M; Pascual A; Rodríguez-Baño J;
Clin Infect Dis; 2013 Nov; 57(9):1225-33. PubMed ID: 23929889
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.
Fätkenheuer G; Preuss M; Salzberger B; Schmeisser N; Cornely OA; Wisplinghoff H; Seifert H
Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):157-62. PubMed ID: 14986158
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
